Generation of Febrile Seizures and Subsequent Epileptogenesis

Bo Feng1, Zhong Chen2

  • 1Department of Pharmacology, Key Laboratory of Medical Neurobiology of the Ministry of Health of China, School of Medicine, Zhejiang University, Hangzhou, 310058, China.

Neuroscience Bulletin
|August 27, 2016
PubMed

Insights

Febrile seizures (FSs) in children can cause lasting brain changes and epilepsy. Understanding fever triggers and epileptogenesis mechanisms is key to prevention and identifying at-risk individuals.

Area of Science:

  • Pediatric Neurology
  • Epileptology
  • Neuroscience

Background:

  • Febrile seizures (FSs) are common in children aged 6 months to 5 years.
  • Complex FSs, unlike simple FSs, may lead to permanent brain changes and increase the risk of temporal lobe epilepsy.
  • The underlying causes of FSs and mechanisms of post-FS epileptogenesis are not fully understood.

Purpose of the Study:

  • To investigate the triggers of fever-induced seizures.
  • To elucidate the mechanisms of epileptogenesis following febrile seizures.
  • To identify risk factors for FS occurrence and post-prolonged FS epileptogenesis.

Main Methods:

  • Review and discussion of existing literature on febrile seizures.
  • Analysis of risk factors associated with FS occurrence.
  • Examination of mechanisms leading to epileptogenesis after prolonged FSs.

Main Results:

  • Complex FSs are implicated in permanent brain modifications and subsequent epilepsy.
  • Identified key questions regarding fever's role in seizure initiation.
  • Summarized risk factors for FS and epileptogenesis.

Conclusions:

  • Understanding FS triggers and epileptogenesis mechanisms is crucial.
  • Identified factors may offer therapeutic targets for FS prevention.
  • Biomarkers for identifying patients at risk of epileptogenesis can be developed.

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.6K
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
2.0K
Increased Body Temperature01:25

Increased Body Temperature

A body temperature above  38°C  (100.4 °F) is known as fever or pyrexia, and a person with fever is termed 'febrile.' Typically, the hypothalamus, a part of the brain that acts as the body's thermostat, regulates body temperature through a thermoregulatory setpoint. It receives signals from cold and warm thermal receptors throughout the body and adjusts the body's temperature accordingly. Fever occurs when this hypothalamic setpoint is altered, usually in...
7.6K
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
1.1K
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.6K
Antiepileptic Drugs: Sodium Channel Blockers01:08

Antiepileptic Drugs: Sodium Channel Blockers

Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
2.1K